{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:07:15Z","timestamp":1778857635643,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radonc.2025.110984","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:24:00Z","timestamp":1749320640000},"page":"110984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma \u2013 Results from a large multicenter analysis of the German Society of Radiation Oncology\u2019s Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)"],"prefix":"10.1016","volume":"209","author":[{"given":"Sina","family":"Heider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-2712","authenticated-orcid":false,"given":"Luisa","family":"Allwohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-897X","authenticated-orcid":false,"given":"Alexander","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-5629","authenticated-orcid":false,"given":"David","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2786-7013","authenticated-orcid":false,"given":"Michael","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-4203","authenticated-orcid":false,"given":"Niklas B.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elgin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1114-2771","authenticated-orcid":false,"given":"Raphael","family":"Bodensohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-4756","authenticated-orcid":false,"given":"Arne","family":"Ruder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilinca","family":"Popp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-4064","authenticated-orcid":false,"given":"Roland","family":"Merten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans T.","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5231-9097","authenticated-orcid":false,"given":"Denise","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folker","family":"Schneller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0948-2125","authenticated-orcid":false,"given":"Elisabeth","family":"Schorb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanna","family":"Wielenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca L.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-5089","authenticated-orcid":false,"given":"Clemens","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110984_b0005","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23551","article-title":"The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-hodgkin's lymphoma","volume":"88","author":"O'Neill","year":"2013","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.radonc.2025.110984_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bjh.14073","article-title":"Trends in primary central nervous system lymphoma incidence and survival in the U.S","volume":"174","author":"Shiels","year":"2016","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.radonc.2025.110984_b0015","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/s41375-022-01582-5","article-title":"Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial","volume":"36","author":"Ferreri","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.radonc.2025.110984_b0020","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2352-3026(23)00371-X","article-title":"High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial","volume":"11","author":"Schorb","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.radonc.2025.110984_b0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/neuonc\/nox187","article-title":"The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades","volume":"20","author":"Mendez","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0030","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1212\/WNL.0000000000008900","article-title":"Management and outcome of primary CNS lymphoma in the modern era: an LOC network study","volume":"94","author":"Houillier","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2025.110984_b0035","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"Ferreri","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.radonc.2025.110984_b0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1200\/JCO.18.00306","article-title":"Radiotherapy or autologous stem-cell transplantation for Primary CNS lymphoma in patients 60 Years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase II PRECIS study","volume":"37","author":"Houillier","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0045","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","article-title":"Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome","volume":"31","author":"Morris","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0050","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.2020.38.15_suppl.2501","article-title":"Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL)","volume":"38","author":"Omuro","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.110984_b0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11060-020-03444-5","article-title":"Outcomes after stereotactic radiosurgery for CNS lymphoma","volume":"147","author":"Palmer","year":"2020","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/jrr\/rrv085","article-title":"Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience","volume":"57","author":"Iwabuchi","year":"2016","journal-title":"Journal of Radiation Research"},{"key":"10.1016\/j.radonc.2025.110984_b0065","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.WNL.0000034256.20173.EA","article-title":"Primary CNS lymphoma: a whole-brain disease?","volume":"59","author":"Lai","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2025.110984_b0070","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19860901)58:5<1106::AID-CNCR2820580521>3.0.CO;2-3","article-title":"Primary malignant lymphoma of the central nervous system","volume":"58","author":"Freeman","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110984_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(81)90060-2","article-title":"Radiation therapy in the management of primary malignant lymphoma of the brain","volume":"7","author":"Berry","year":"1981","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110984_b0080","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ijrobp.2006.03.061","article-title":"Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: results of north central cancer treatment group (NCCTG) 96-73-51","volume":"65","author":"Laack","year":"2006","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110984_b0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG 8315","volume":"23","author":"Nelson","year":"1992","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110984_b0090","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation therapy oncology group study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0095","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0100","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","article-title":"Delayed neurotoxicity in primary central nervous system lymphoma","volume":"62","author":"Omuro","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.radonc.2025.110984_b0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11060-019-03257-1","article-title":"Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation","volume":"144","author":"Correa","year":"2019","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0110","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/bloodadvances.2022007011","article-title":"Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study","volume":"6","author":"Lesueur","year":"2022","journal-title":"Blood Advances"},{"key":"10.1016\/j.radonc.2025.110984_b0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.clon.2014.06.011","article-title":"Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated","volume":"26","author":"Shibamoto","year":"2014","journal-title":"Clinical Oncology (Royal College of Radiologists)"},{"key":"10.1016\/j.radonc.2025.110984_b0120","first-page":"1481","article-title":"Surgery for primary CNS lymphoma?","volume":"14","author":"Weller","year":"2012","journal-title":"Challenging a paradigm Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110984_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.11.010","article-title":"Primary central nervous system lymphomas: EHA-ESMO clinical Practice guideline for diagnosis, treatment and follow-up","author":"Ferreri","year":"2024","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/neuonc\/noad177","article-title":"Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas","volume":"26","author":"Lauer","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-015-1786-1","article-title":"Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma","volume":"123","author":"Hirono","year":"2015","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110984_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106457","article-title":"Gamma knife stereotactic radiosurgery as an effective tool in primary CNS lymphoma: evaluation of stereotactic radiosurgery and methotrexate treatment in a prospective and observational clinical research study","volume":"201","author":"Alvarez-Pinzon","year":"2021","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.radonc.2025.110984_b0145","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1111\/bjh.16759","article-title":"Ibrutinib in patients with relapsed\/refractory central nervous system lymphoma: a retrospective single-centre analysis","volume":"190","author":"Lauer","year":"2020","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.radonc.2025.110984_b0150","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ajh.27316","article-title":"CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: real-life results of the LOC network","volume":"99","author":"Choquet","year":"2024","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.radonc.2025.110984_b0155","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1182\/bloodadvances.2024013393","article-title":"CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas","volume":"8","author":"Cederquist","year":"2024","journal-title":"Blood Advances"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:40Z","timestamp":1761128560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025044883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S0167814025044883"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110984","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma \u2013 Results from a large multicenter analysis of the German Society of Radiation Oncology\u2019s Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110984"}}